New York, NY -- (ReleaseWire) -- 01/30/2013 -- Growing Stock Report initiates a Biotech Stock Watch List for the following Stock: ARCA biopharma, Inc. (NASDAQ:ABIO).
ARCA biopharma, Inc. (NASDAQ:ABIO) a biopharmaceutical company that focuses on developing genetically-targeted therapies for cardiovascular diseases is up (+74.68%) in pre-market trading. ARCA biopharma, Inc. (NASDAQ:ABIO) provided an update on a proposed, genetically-targeted clinical trial in atrial fibrillation (“AF”) of the Company’s lead developmental drug, Gencaro (bucindolol hydrochloride). The Company also announced that Medtronic, Inc. (NYSE:MDT), a leader in medical technologies to improve the treatment of chronic diseases, including cardiac rhythm disorders, has signed a non-binding Letter of Intent to collaborate on the initial, Phase 2B portion of the proposed trial.
Click Here to find out what The Street and other Investors are saying about ARCA biopharma, Inc.
Also mentioned in Growing Stock Report's Biotech Stock Watch Report in conjunction with ARCA biopharma, Inc. (NASDAQ:ABIO) was Medtronic, Inc. (NYSE:MDT)
Click Here to find out what The Street and other Investors are saying about Medtronic, Inc. (NYSE:MDT).
GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.GrowingStockReport.com
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Vipstockreport.com website, for complete risks and disclosures.
Growing Stock Report